These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333 [TBL] [Abstract][Full Text] [Related]
3. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo. Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361 [TBL] [Abstract][Full Text] [Related]
4. Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II. Criscuolo E; Giuliani B; Ferrarese R; Ferrari D; Locatelli M; Clementi M; Mancini N; Clementi N J Med Virol; 2023 Mar; 95(3):e28643. PubMed ID: 36890648 [TBL] [Abstract][Full Text] [Related]
5. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population. Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197 [TBL] [Abstract][Full Text] [Related]
7. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. Rao AK; Petersen BW; Whitehill F; Razeq JH; Isaacs SN; Merchlinsky MJ; Campos-Outcalt D; Morgan RL; Damon I; Sánchez PJ; Bell BP MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(22):734-742. PubMed ID: 35653347 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection. Manenti A; Solfanelli N; Cantaloni P; Mazzini L; Leonardi M; Benincasa L; Piccini G; Marchi S; Boncioli M; Spertilli Raffaelli C; Tacconi D; Mattiuzzo G; Kistner O; Montomoli E; Trombetta CM Front Public Health; 2023; 11():1195674. PubMed ID: 37415699 [TBL] [Abstract][Full Text] [Related]
10. Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies. Sudarmaji N; Kifli N; Hermansyah A; Yeoh SF; Goh BH; Ming LC Viruses; 2022 Nov; 14(11):. PubMed ID: 36423105 [TBL] [Abstract][Full Text] [Related]
11. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history. Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185 [TBL] [Abstract][Full Text] [Related]
12. Protection of mice against the highly pathogenic VV Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905 [TBL] [Abstract][Full Text] [Related]
13. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115 [TBL] [Abstract][Full Text] [Related]
14. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks. Islam MR; Hossain MJ; Roy A; Hasan AHMN; Rahman MA; Shahriar M; Bhuiyan MA Health Sci Rep; 2022 Sep; 5(5):e798. PubMed ID: 36032515 [TBL] [Abstract][Full Text] [Related]
16. Current Status of Vaccine Development for Monkeypox Virus. Rastogi A; Kumar M Adv Exp Med Biol; 2024; 1451():289-300. PubMed ID: 38801585 [TBL] [Abstract][Full Text] [Related]
17. Poxvirus Vaccines: Past, Present, and Future. Jhancy M Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584 [TBL] [Abstract][Full Text] [Related]
18. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022. Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741 [TBL] [Abstract][Full Text] [Related]
19. An overview on mRNA-based vaccines to prevent monkeypox infection. Natami M; Gorgzadeh A; Gholipour A; Fatemi SN; Firouzeh N; Zokaei M; Mohammed Ali SH; Kheradjoo H; Sedighi S; Gholizadeh O; Kalavi S J Nanobiotechnology; 2024 Mar; 22(1):86. PubMed ID: 38429829 [TBL] [Abstract][Full Text] [Related]